Ehlers–Danlos syndrome is not just one condition, but a complex family of thirteen disorders.
In short: Often misunderstood as simple joint flexibility, Ehlers–Danlos syndrome encompasses thirteen distinct genetic conditions affecting connective tissue. While some forms are mild, others cause life-threatening vascular complications. Because symptoms vary wildly and the most common type lacks a genetic test, diagnosis remains a significant challenge for the medical community.
Ehlers–Danlos syndrome (EDS) represents a group of thirteen genetic disorders characterized by defects in the structure or processing of proteins like collagen and tenascin. These connective tissues are found throughout the body, meaning the impact of EDS extends far beyond the joints and skin. While symptoms like loose joints, velvety skin, and abnormal scarring are common, the condition can manifest in unexpected ways, including cardiovascular issues, gastrointestinal dysfunction, and pelvic organ prolapse.
The classification system, last updated in 2017, categorizes these syndromes based on specific gene mutations. For example, classical EDS is often linked to variations in COL5A1 and COL5A2 genes, while vascular EDS—the most severe form—is typically caused by mutations in the COL3A1 gene. Other rare types, such as dermatosparaxis EDS, are associated with the ADAMTS2 gene. Despite these genetic insights, the most prevalent form, hypermobile Ehlers–Danlos syndrome (hEDS), remains a diagnostic mystery because no specific genetic marker has been identified for it.
Because of this lack of a definitive test for hEDS, patients are frequently misdiagnosed with conditions like depression or chronic fatigue syndrome. Diagnosis for hEDS relies on clinical criteria and physical assessments. Treatment is entirely supportive, focusing on physical therapy, bracing, and pain management, as no cure currently exists. While some patients maintain a normal life expectancy, those with vascular involvement face significantly higher risks, highlighting the critical importance of accurate subtype identification in managing this diverse group of disorders.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ehlers–Danlos syndrome
To cite this card, link to https://intellectplus.co.uk/app/science-ehlers-danlos-syndrome.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Human body & genes · More in Science · Latest · A–Z · All topics